YOUSSEF AOUNI: Open Payments
NPI 1720654650 · EUSTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 25 payments from 9 companies in 2025. Trend: 2023 $970 · 2024 $1,255 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $170 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Merck Sharp & Dohme LLC | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| PFIZER INC. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: REXULTI, REPATHA, VERQUVO, EVENITY, Kerendia, VYNDAQEL, FARXIGA, LifeVest.
Industry payments across FL — which companies pay providers there.
